The National Institute on Drug Abuse (NIDA) seeks research for the discovery and development of medications to prevent and treat opioid use disorder (OUD) and/or psychostimulant (cocaine or methamphetamine) use disorder (PsUD) and overdose.
Deadlines:
- Letter of Intent Due Date(s): 30 days prior to the application due date
- Application Due Date(s): Applications will be accepted on a rolling basis, beginning on September 3, 2022.
- AIDS Application Due Date(s): Applications will be accepted on a rolling basis, beginning on September 3, 2022.
PAR-22-200 Expiration Date September 02, 2025